DGAP-News: Medical Marijuana Inc.'s Dixie Elixirs Brand to Co-Sponsor Premiere of Snoop Lion Movie 'Reincarnated' During 4/20 Week


Medical Marijuana Inc. 

16.04.2013 00:30
---------------------------------------------------------------------------

SAN DIEGO, 2013-04-16 00:30 CEST (GLOBE NEWSWIRE) --
 Medical Marijuana Inc. (OTC:MJNA), a leading hemp industry innovator,
announced that its portfolio company, Red Dice Holdings, LLC brand Dixie
Elixirs and Edibles, has completed negotiations with The Cashmere Agency,
representative for hip-hop and reggae superstar Snoop Lion. Dixie will co-host
the exclusive 'green carpet screening' of Snoop Lion's upcoming 'Reincarnated'
movie premiere on Friday, April 19th, at The Fillmore Auditorium in Denver,
Colorado. The premiere coincides with the '420 weekend' events that will take
place during that time period. 

'The upcoming 420 events here in Colorado represent new opportunities for
cannabis businesses including our Dixie brand,' said Tripp Keber, CEO of Red
Dice Holdings. 'For the first time in our nation's history, an adult twenty-one
years and older can access this powerful plant for whatever purpose he or she
deems appropriate. This creates a significant marketing opportunity for our
company and Dixie's alignment with the Snoop Lion brand positions us to take
full advantage of what Amendment 64 now offers residents of the State of
Colorado.' 

In November, 2012 general election, Colorado voters passed Amendment 64, which
in effect legalized cannabis for adult use. Those 21 years or older can possess
one ounce of cannabis. Further legislation enactment is likely to allow
non-Colorado residents 21 and older to possess up to 1/4 ounce. 

The Dixie Elixirs and Edibles brand is well positioned to serve both the
medical cannabis and adult use markets as Amendment 64 continues to be
implemented. Currently, the company offers 12 distinct product lines and
delivery systems, featuring over 80 unique products, under the Dixie Classic,
Dixie Botanicals and Dixie X umbrellas. Some products include Dixie Ginger
Mango Dew Drops, Dixie Botanicals Hemp Salvation Balm and Dixie Elixirs
Sparkling Pomegranate. Dixie products are found in the majority of Colorado's
500+ Medical Marijuana Centers (MMCs). 

The adult use market for cannabis in Colorado and Washington is expected to
grow substantially. According to http://www.mmjbusinessdaily.com, 'In 2014, the
emergence of cannabis retail stores in Colorado and Washington could generate
roughly $1 billion in state-legal cannabis sales during the first full year of
operation.'1 

When taking into account the 600,000+approximately 58 million tourists that
visit Colorado each year , the adult market for cannabis consumption should
increase by a factor of ten-fold.2 

Keber added 'We are excited to participate alongside a world-class performer to
celebrate the forthcoming 420 event, and we intend this to be the first of many
campaigns to leverage this ever-growing segment of the cannabis industry.' 

1)
http://mmjbusinessdaily.com/2013/03/21/us-medical-marijuana-sales-estimated-at-1
-5b-in-2013-cannabis-industry-could-quadruple-by-2018/ 

2)
http://summitcountyvoice.com/2012/06/22/colorado-tourism-showed-strength-in-2011
/#more-44384 

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators,
leveraging our team of professionals to source, evaluate and purchase
value-added companies and products, while allowing them to keep their integrity
and entrepreneurial spirit. We strive to create awareness within our industry,
develop environmentally friendly, economically sustainable businesses, while
increasing shareholder value. 

Medical Marijuana Inc. does not grow, sell or distribute any substances that
violate United States Law or the controlled substance act. 

For more information, please visit the company's website at:
www.MedicalMarijuanaInc.com. 

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject
to the Safe Harbor created by those sections. This material contains statements
about expected future events and/or financial results that are forward-looking
in nature and subject to risks and uncertainties. Such forward-looking
statements by definition involve risks, uncertainties and other factors, which
may cause the actual results, performance or achievements of Medical Marijuana,
Inc. to be materially different from the statements made herein. 

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE These statements have not been
evaluated by the Food and Drug Administration (FDA). These products and
statements are not intended to diagnose, treat, cure, or prevent any disease. 


         CONTACT: Corporate Contact: Medical Marijuana, Inc.
         Toll Free: 888-OTC-MJNA (888-682-6562)
         www.medicalmarijuanainc.com
         www.facebook.com/mjnainc
         
         Investor Relations Contact:
         Stuart T. Smith SmallCapVoice.Com, Inc.
         P. 512-267-2430 F. 512-267-2530
         Email: ssmith@smallcapvoice.com
         Skype: SmallCapVoice.com
         AIM: SmallCapVoice7
News Source: NASDAQ OMX



16.04.2013 Dissemination of a Corporate News, transmitted by DGAP - 
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Medical Marijuana Inc.
              
               
              United States
Phone:        
Fax:          
E-mail:       
Internet:     
ISIN:         US58463A1051
WKN:          
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------